These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8111297)

  • 41. Effect of aminoguanidine on post-ischemic damage in rodent model of stroke.
    Vakili A; Zahedi-Khorasani M
    Pak J Pharm Sci; 2008 Jan; 21(1):24-8. PubMed ID: 18166515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of amiridine on rat learning in a radial maze].
    Burov IuV; Borisova AO; Robakidze TN
    Biull Eksp Biol Med; 1996 May; 121(5):526-7. PubMed ID: 8744128
    [No Abstract]   [Full Text] [Related]  

  • 43. Cholinesterase inhibitors and use of psychotropic medications in a sample of patients with dementia.
    Shamsi M; Rice K; Rao VB
    J Am Geriatr Soc; 2007 Dec; 55(12):2099-100. PubMed ID: 18081685
    [No Abstract]   [Full Text] [Related]  

  • 44. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 1. EEG mapping, psychometric and tolerability findings.
    Saletu-Zyhlarz GM; Anderer P; Wolzt M; Semlitsch HV; Assandri A; Nessi P; Nannipieri F; Rosini S; Saletu B
    Neuropsychobiology; 2009; 59(2):100-9. PubMed ID: 19365150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The combined neuroprotective effects of lidocaine and dexmedetomidine after transient forebrain ischemia in rats.
    Goyagi T; Nishikawa T; Tobe Y; Masaki Y
    Acta Anaesthesiol Scand; 2009 Oct; 53(9):1176-83. PubMed ID: 19388884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate.
    Minato H; Kikuta C; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Nimodipine and experimental combined disorders of cerebral and coronary circulation].
    Mirzoian RS; Khaĭlov NA; Tsorin IB; Gan'shina TS
    Eksp Klin Farmakol; 2009; 72(2):24-8. PubMed ID: 19441723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Possibility of predicting the therapeutic effectiveness of psychotropic preparations based on an analysis of the biological indices].
    Minsker EI
    Vestn Akad Med Nauk SSSR; 1979; (7):60-6. PubMed ID: 539098
    [No Abstract]   [Full Text] [Related]  

  • 49. Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use.
    Moonis M; Fisher M
    Expert Rev Cardiovasc Ther; 2003 Nov; 1(4):611-5. PubMed ID: 15030260
    [No Abstract]   [Full Text] [Related]  

  • 50. [Comparative study of nicardipine versus placebo in the prevention of cognitive deterioration in patients with transient ischemic attack].
    Moltó JM; Falip R; Martín R; Insa R; Pastor I; Matías-Guiu J
    Rev Neurol; 1995; 23(119):54-8. PubMed ID: 8548644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bioequivalency and pharmacodynamics of psychotropic drugs based on computer-analyzed EEG.
    Itil TM
    Psychopharmacol Bull; 1976 Oct; 12(4):60-1. PubMed ID: 972993
    [No Abstract]   [Full Text] [Related]  

  • 52. Electroencephalographic studies of psychopharmaca in Czechoslovakia. An overview.
    Mrna B
    Acta Univ Palacki Olomuc Fac Med; 1985; 108():289-94. PubMed ID: 3161286
    [No Abstract]   [Full Text] [Related]  

  • 53. [On the nonspecific hyperventilation effect in the EEG of healthy children. II. Structure details and conclusions].
    Daute KH; Klust E; Frenzel J
    Z Kinderheilkd; 1968 Oct; 104(3):208-17. PubMed ID: 5724304
    [No Abstract]   [Full Text] [Related]  

  • 54. [The tolerance of Dormutil in animal experiments and in children with cerebral spasm attacks].
    Rohmann E; Külz J
    Kinderarztl Prax; 1970 May; 38(5):204-8. PubMed ID: 5483877
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluation of psychotropic drug therapy in chronic hyperventilation syndrome: intensive study design.
    Aronson PR
    J New Drugs; 1966; 6(5):305-7. PubMed ID: 5339422
    [No Abstract]   [Full Text] [Related]  

  • 56. [The neuro- and psychophysiological effects of bromantane].
    Viatleva OA; Barchukov VG; Morozov IS; Salenko IuA; Zhirnov EN
    Voen Med Zh; 2000 Aug; 321(8):61-5, 96. PubMed ID: 10998997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Guidelines for pharmaco-EEG studies in man. Expert group, organized of the Federal Health Office, Institute for Drugs, Berlin (West), Germany.
    Pharmacopsychiatria; 1982 May; 15(3):107-8. PubMed ID: 7048353
    [No Abstract]   [Full Text] [Related]  

  • 58. [Spasm in cerebral vascular disease].
    Galibert P
    Ann Cardiol Angeiol (Paris); 1981; 30(2):84-8. PubMed ID: 7259050
    [No Abstract]   [Full Text] [Related]  

  • 59. [The neurophysiological mechanisms of the action of nootropic preparations].
    Krapivin SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(4):104-7. PubMed ID: 8122449
    [No Abstract]   [Full Text] [Related]  

  • 60. Introduction and history of the use of electroencephalography in animal drug studies.
    van Riezen H; Glatt AF
    Neuropsychobiology; 1993; 28(3):118-21. PubMed ID: 8278028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.